Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.

Abstract We have developed an efficient and selective radioligand, the [ 35 S]-radiolabeled dihydroquinoxalinone derivative, 4 , for an ex vivo receptor occupancy assay in transgenic rats over-expressing the human bradykinin B 1 receptor.